Syntekabio, Inc., An NGS and AI driven drug discovery and development company.
Location: South Korea, Daejeon
Employees: 11-50
Founded date: 2009
Investors 4
| Date | Name | Website |
| - | Timewise I... | cjvc.com |
| 18.05.2023 | Synergy IB... | synergyib.... |
| - | TimewiseIn... | timewisein... |
| - | The Yozma ... | korea.yozm... |
Mentions in press and media 2
| Date | Title | Description |
| 02.09.2024 | Syntekabio collaborates with global compound supplier Enamine for AI-based synthetic drug development | KYIV, UKRAINE, September 2, 2024 /EINPresswire.com/ -- Syntekabio collaborates with global compound supplier Enamine on AI-driven synthetic drug development and global market expansion through a strategic partnership. Syntekabio (CEO Jongsu... |
| 12.08.2022 | AI-Based Drug Discovery and Development Company Syntekabio Begins US Operations | Syntekabio offers AI drug discovery and development platforms as a cloud service in the US and global pharmaceutical markets. Syntekabio offers innovative AI drug discovery solutions for the global biopharma industry, including DeepMatcher®... |